NCT04886284View on ClinicalTrials.gov

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
Staphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaStaphylococcal SepsisStaphylococcus Aureus Endocarditis
Interventions
DRUG

Ertapenem

Adjunctive ertapenem

DRUG

Placebo

Saline placebo

Trial Locations (5)

T2N4Z6

RECRUITING

Foothills Medical Centre, Calgary

L8P1A2

RECRUITING

Hamilton Health Sciences (Hamilton General Hospital and Juravinski Hospital), Hamilton

L2E6X2

RECRUITING

Niagara Health - Niagara Falls Site, Niagara Falls

Unknown

RECRUITING

Hospital de la Cité de la Sante, Laval

H4A3J1

RECRUITING

McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital), Montreal

All Listed Sponsors
lead

Todd C. Lee MD MPH FIDSA

OTHER